发明授权
US07833520B2 Method of using interferon-like protein ZCYTO21(IL-29) to treat hepatitis B
有权
使用干扰素样蛋白ZCYTO21（IL-29）治疗乙型肝炎的方法
- 专利标题： Method of using interferon-like protein ZCYTO21(IL-29) to treat hepatitis B
- 专利标题（中）： 使用干扰素样蛋白ZCYTO21（IL-29）治疗乙型肝炎的方法
-
申请号： US12628078申请日： 2009-11-30
-
公开(公告)号： US07833520B2公开(公告)日： 2010-11-16
- 发明人: Paul O. Sheppard , Scott R. Presnell , Brian A. Fox , Teresa Gilbert , Betty A. Haldeman , Francis J. Grant
- 申请人： Paul O. Sheppard , Scott R. Presnell , Brian A. Fox , Teresa Gilbert , Betty A. Haldeman , Francis J. Grant
- 申请人地址： US TN Nashville
- 专利权人： ZymoGenetics, LLC
- 当前专利权人： ZymoGenetics, LLC
- 当前专利权人地址： US TN Nashville
- 代理商 Brian J. Walsh
- 主分类号： A61K38/20
- IPC分类号： A61K38/20 ; A61K38/21 ; A61K38/00 ; C07K14/00
摘要：
The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.
公开/授权文献
信息查询
IPC分类:
